FDA Investigator Marissa S Steinhagen

Marissa S Steinhagen has conducted inspections on 196 sites in 11 countries as of 13 May 2019. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
196
Last Inspection Date:
13 May 2019
Investigator Role:
FDA Investigator
Redica ID:
100002646
Countries of Inspections:
United States of America, Israel, Japan, Finland, Germany, Korea (Republic of), Mexico, United Kingdom of Great Britain and Northern Ireland, Thailand, Spain, Switzerland
FDA Investigators that have inspected at least one site in common with Marissa S Steinhagen:
Aaron L Dunbar, Aimee J Edwin, Alan R Albrecht, Albert L Nguyen, Alexey Khrenov, PhD, Alice S Tsao, Alison A Nicoli, Alison A Stone, Allison M Scheck, Althea A Williams, Amanda Dinaro, Amber M Capello Jones, Amy L Mcintyre, Amy S Graf, Ana M Placencia, Anissa M Vargas, Annabelle Crusan, D,VM, Anthony J Ladner, Anthony L Nicoli, Anthony R Petriella, April L Brown, April L Young, Arthur G Hurst, Bei Y He, Benjamin E Bowen, Benjamin J Dastoli, Benjamin W Anderson, Billi Jom Johnson, Bleta Vuniqi, Bradley A Servais, Carolyn A Warren, Catherine J Laufmann, Charles D Brown, Charles M Spyr, Christina A Castineyra, Christina L Bigham, Christine A Harman, PhD, Christopher B May, Christopher R Czajka, Clifford F Long, Corey K Reno, Courtney R Ingalsbe, Courtney R Tiegs, Darren D Holaday, Dawn M Braswell, Demetria L Lueneburg, Denise L Burosh, Dianna C Sonnenburg, Dolores Harper, Donald W Myrick, Douglas J Snyder, Douglas W Atkins, Dr. Jason R Caballero, Edward A Fabiano, Elizabeth P Mayer, Eric M Padgett, Eric S Pittman, Fannie M Harrell, Francis A Guidry, Garrett W Steiner, Gary Durbiel Goldner, Gina M Scholze, Grant M Ruis, Greg W Smith, Gregory A Berg, Gregory W Smith, Heather Akleimola Hulbert, Howard A Burmester, Ivan E Reyes, Jaclyn N Munsch, James A Beaulieu, James A Jagon, James A Lane, James E Frye, Janis R Armedoriz, Jasjeet K Sekhon, Jay V Jariwala, Jennifer M Gogley, Jennifer S Ness, Jeremy L Tri, Jessica L Johnson, Joan Johnson, Jocelyn M Muggli, Joey C West, John E Emmert, Joseph A Piechocki, Joseph D Gong, Joseph M Edwin, Joshua J Silvestri, Justin A Boyd, Justin A Hefferman, Karen M Labounty, Karen M Montgomery (KMM), Karla J Youngberg, Kellia N Hicks, Kellie L Thommes, RN, Kellie L Westerbuhr, Kenneth A Libertoski, Kevin P Regan, Kimberly Lewandowski Walker, Kristy E Zuroski, Kyle J Mccracken, Laiza V Garcia, Lauren E Merz, Lauren E Sanger, Leila G Lackey, Lori B Wikstrom, Lori S Lawless, Mada A Tautges, Maria E Treadwell, Marie A Fadden, Marissa S Henning, Martha Sullivan Myrick, Mary A Millner, Mary K Concannon, Melanie W Pishnery, Melissa D Kalik, Melissa I Michurski, Melissa J Holz, Melissa J Ireland, Michael R Goga, Michelle J Glembin, Mildred J Tures, Mohammed H Adam, Mra Mcculloughj, Msdap Gonzlezk, Nancy G Schmidt, Natasha R Johnson, Nicholas R Nance, Nicholas T Domer, Nicholas Z Lu, Nicole C Victoria, PhD, Nikki S Bryant, Noreen Muñiz, Norman Wong, Paola E Lathrop, Ralph Jerndal, Ralph W Jemdal, Rebecca L Caulfield, Rebecca L Mullikin, Rhonda L Mecl, Richard Heath Coats, Richard Jay Tucker, RS, Robert C Coleman, Robert H Claflin, Robert J Waldorf, Ross J Grigsby, Rostislav Servetnyk, Roy Baby, Ryan J Benedict, Sana A Elassar, Sandra Sejdinovic, Scott A Golladay, Scott L Schenian, Seneca D Toms, Shannon M Berg, Sharon K Thoma, PharmD, Sharon L Matson, Shaun M Olson, Steven A Skaar, Steven R Ziser, Susan A Atcher, Susan M Atcher, Susan M Jackson, Susan M Matthias, Susan Yu, Tara C Singh, Theresa C Klaman, Tiffany P Kelley, Timothy G Philips, Timothy R Marrs, Tony T Yang, Toyin B Oladimeji, Tyler R Courtney, Ulysses D Singleton, William D Tingley, Yehualashet A Gessesse, Yoon K Oh

Marissa S Steinhagen's Documents

Publish Date Document Type Title
June, 2014 FDA 483 Express Diagnostics Int'l., Inc. - Form 483, 2014-06-24
July, 2010 FDA 483 Medivators, Inc. - Form 483, 2010-07-12
February, 2012 FDA 483 Nextern Innovation, Inc. - Form 483, 2012-02-23
February, 2014 FDA 483 Mar Cor Purification - Form 483, 2014-02-18
February, 2010 FDA 483 R&D Batteries Inc - Form 483, 2010-02-10
March, 2015 EIR Premier Biotech, Inc. - EIR, 2015-03-16
October, 2015 FDA 483 Medtronic Neuromodulation - Form 483, 2015-10-26
March, 2009 EIR Boston Scientific Corporation - EIR, 2009-03-13
December, 2015 EIR Sterilmed, Inc. - EIR, 2015-12-02
September, 2010 FDA 483 Medtronic Inc. - Form 483, 2010-09-02
January, 2017 FDA 483 Augustine Temperature Management, LLC - Form 483, 2017-01-04
September, 2016 EIR DSM Nutritional Products Ltd Branch Pentapharm - EIR, 2016-10-24
June, 2009 FDA 483 Prestige Products, Inc. - Form 483, 2009-06-10
September, 2017 FDA 483 Boston Scientific Corporation - Form 483, 2017-09-22
September, 2018 FDA 483 Unipower Corp - Form 483, 2018-09-20
September, 2009 FDA 483 Nustar Inc - Form 483, 2009-09-30
February, 2019 FDA 483 Sharplight Technologies - Form 483, 2019-02-14
October, 2014 FDA 483 Respiratory Technologies, Inc. - Form 483, 2014-10-09
September, 2011 FDA 483 Fagron Inc - Form 483, 2011-09-30
April, 2016 FDA 483 St. Jude Medical - Form 483, 2016-04-11
September, 2017 EIR Steris Laboratories - EIR, 2017-09-22
October, 2015 FDA 483 Response Medtronic Neuromodulation - Form 483R, 2015-11-17
July, 2012 EIR Lobana Industries LLC - EIR, 2012-07-11
August, 2018 FDA 483 Preservation Solutions, Inc. - Form 483, 2018-08-10
April, 2016 EIR St. Jude Medical - EIR, 2016-04-11
September, 2014 FDA 483 Envoy Medical Corporation - Form 483, 2014-09-04
May, 2019 FDA 483 Vasamed, Inc. - Form 483, 2019-05-16
May, 2012 FDA 483 Medtronic Neuromodulation - Form 483, 2012-05-09
July, 2016 FDA 483 Nypro, Inc. - Form 483, 2016-07-06
July, 2012 FDA 483 Lobana Industries LLC - Form 483, 2012-07-11

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more